• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种简单的适应方法提高了复合终点预测模型的可解释性。

A simple adaptation method improved the interpretability of prediction models for composite end points.

机构信息

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, PO Box 85500, 3508 GA Utrecht, The Netherlands.

出版信息

J Clin Epidemiol. 2012 Sep;65(9):946-53. doi: 10.1016/j.jclinepi.2012.01.021. Epub 2012 May 31.

DOI:10.1016/j.jclinepi.2012.01.021
PMID:22658619
Abstract

OBJECTIVE

The pros and cons of composite end points in prognostic research are discussed, and an adaptation method, designed to accurately adjust absolute risks for a composite end point to risks for the individual component outcomes, is presented.

STUDY DESIGN AND SETTING

An example prediction model for recurrent cardiovascular events (composite end point) was used to evaluate the performance regarding the individual component outcomes (cardiovascular death, myocardial infarction, and stroke) before and after the adaptation method.

RESULTS

Discrimination for the individual component outcomes (concordance index for myocardial infarction, 0.68; concordance index for stroke, 0.70) was very similar to discrimination for the original composite end point (concordance index, 0.70). For cardiovascular death, it even increased substantially (concordance index, 0.78). After adaptation, calibration plots for the component outcomes also improved, with visible convergence of the predicted risks and the observed incidences.

CONCLUSION

In sum, these findings show that the adaptation method is useful when validating or applying a composite end point prediction model to the individual component outcomes. Following from this, recommendations concerning reporting of composite end points in future research are also included. Without the need for extra data, composite end point prediction models can easily be directly expanded to allow for the estimation of risk for each individual component outcome, improving the interpretability for clinicians and patients.

摘要

目的

讨论预后研究中复合终点的优缺点,并提出一种适应方法,旨在准确调整复合终点的绝对风险,以适应各个组成部分结局的风险。

研究设计和设置

使用预测复发性心血管事件(复合终点)的示例预测模型,在适应方法之前和之后评估各个组成部分结局(心血管死亡、心肌梗死和中风)的性能。

结果

各个组成部分结局的区分度(心肌梗死的一致性指数为 0.68;中风的一致性指数为 0.70)与原始复合终点的区分度非常相似(一致性指数为 0.70)。对于心血管死亡,甚至有显著提高(一致性指数为 0.78)。适应后,各个组成部分的校准图也得到了改善,预测风险和观察到的发生率明显趋同。

结论

总之,这些发现表明,当验证或将复合终点预测模型应用于各个组成部分结局时,适应方法非常有用。由此,也包括了对未来研究中报告复合终点的建议。无需额外的数据,复合终点预测模型可以轻松扩展,以估计每个个体组成部分结局的风险,提高临床医生和患者的可解释性。

相似文献

1
A simple adaptation method improved the interpretability of prediction models for composite end points.一种简单的适应方法提高了复合终点预测模型的可解释性。
J Clin Epidemiol. 2012 Sep;65(9):946-53. doi: 10.1016/j.jclinepi.2012.01.021. Epub 2012 May 31.
2
The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.心血管研究中复合终点的问题:主要不良心脏事件与经皮冠状动脉介入治疗的故事
J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034.
3
Methods to evaluate risks for composite end points and their individual components.评估复合终点及其各个组成部分风险的方法。
J Clin Epidemiol. 2004 Feb;57(2):113-22. doi: 10.1016/j.jclinepi.2003.02.001.
4
Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS).中风后血管风险预测 - 前瞻性中风队列(PROSCIS)的方案和试点数据。
Int J Stroke. 2013 Aug;8(6):484-90. doi: 10.1111/j.1747-4949.2012.00871.x. Epub 2012 Aug 29.
5
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).阿托伐他汀预防2型糖尿病患者心血管终点事件的疗效与安全性:非胰岛素依赖型糖尿病阿托伐他汀预防冠心病终点事件研究(ASPEN)
Diabetes Care. 2006 Jul;29(7):1478-85. doi: 10.2337/dc05-2415.
6
Informed choice of composite end points in cardiovascular trials.心血管试验中复合终点的明智选择。
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):170-8. doi: 10.1161/CIRCOUTCOMES.113.000149. Epub 2014 Jan 14.
7
Cardiovascular morbidity associated with nonadherence to statin therapy.与不坚持他汀类药物治疗相关的心血管疾病发病率
Pharmacotherapy. 2005 Aug;25(8):1035-43. doi: 10.1592/phco.2005.25.8.1035.
8
Determining the most appropriate components for a composite clinical trial outcome.确定复合临床试验结果最合适的组成部分。
Am Heart J. 2008 Oct;156(4):633-40. doi: 10.1016/j.ahj.2008.05.018. Epub 2008 Jul 31.
9
Key issues in end point selection for heart failure trials: composite end points.心力衰竭试验终点选择的关键问题:复合终点
J Card Fail. 2005 Oct;11(8):567-75. doi: 10.1016/j.cardfail.2005.08.350.
10
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.心肌梗死后肾功能不全与心血管结局之间的关系。
N Engl J Med. 2004 Sep 23;351(13):1285-95. doi: 10.1056/NEJMoa041365.

引用本文的文献

1
Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals.基于不同时间间隔,探究从轻度认知障碍向阿尔茨海默病进展的预测因子。
Age Ageing. 2023 Sep 1;52(9). doi: 10.1093/ageing/afad182.
2
Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.预测模型研究系统评价的严格评价与数据提取:CHARM 清单
PLoS Med. 2014 Oct 14;11(10):e1001744. doi: 10.1371/journal.pmed.1001744. eCollection 2014 Oct.